Reported about 2 months ago
Eli Lilly has announced significant price reductions for its weight-loss drug Zepbound, lowering the monthly cost to $399 for the 2.5mg dose and $549 for the 5mg dose, down from the original $1,060 price. This decision comes as part of a strategy to enhance accessibility amidst the ongoing GLP-1 medication shortages. The new pricing aligns with the company's aim to target caregivers and patients paying out-of-pocket, particularly through its LillyDirect platform. The changes reflect Lilly's efforts to maintain market dominance in the competitive weight-loss drug segment.
Source: YAHOO